These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 25511654)

  • 1. [Hereditary angioedema biological diagnosis].
    Ponard D
    Presse Med; 2015 Jan; 44(1):57-64. PubMed ID: 25511654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angioedema Without Wheals: Challenges in Laboratorial Diagnosis.
    Grumach AS; Veronez CL; Csuka D; Farkas H
    Front Immunol; 2021; 12():785736. PubMed ID: 34956216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
    Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M
    Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
    Zeerleder S; Levi M
    Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype.
    Grivčeva-Panovska V; Košnik M; Korošec P; Andrejević S; Karadža-Lapić L; Rijavec M
    Ann Med; 2018 May; 50(3):269-276. PubMed ID: 29513108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology.
    Sinnathamby ES; Issa PP; Roberts L; Norwood H; Malone K; Vemulapalli H; Ahmadzadeh S; Cornett EM; Shekoohi S; Kaye AD
    Adv Ther; 2023 Mar; 40(3):814-827. PubMed ID: 36609679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition and classification of hereditary angioedema.
    Proper SP; Lavery WJ; Bernstein JA
    Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S03-S07. PubMed ID: 33109317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity.
    Wu MA; Castelli R
    Clin Chem Lab Med; 2016 Feb; 54(2):207-14. PubMed ID: 26068904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of hereditary angioedema.
    Canonica GW; Rossi O
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of chromogenic and ELISA functional C1 inhibitor tests in diagnosing hereditary angioedema.
    Li HH; Busse P; Lumry WR; Frazer-Abel A; Levy H; Steele T; Dayno J; Riedl M
    J Allergy Clin Immunol Pract; 2015; 3(2):200-5. PubMed ID: 25609336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment.
    Magerl M; Germenis AE; Maas C; Maurer M
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
    Joseph K; Tholanikunnel TE; Kaplan AP
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes.
    Joseph K; Bains S; Tholanikunnel BG; Bygum A; Aabom A; Koch C; Farkas H; Varga L; Ghebrehiwet B; Kaplan AP
    Allergy; 2015 Jan; 70(1):115-9. PubMed ID: 25186184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemistry, molecular genetics, and clinical aspects of hereditary angioedema with and without C1 inhibitor deficiency.
    Miyata T; Horiuchi T
    Allergol Int; 2023 Jul; 72(3):375-384. PubMed ID: 37169642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency.
    Loules G; Zamanakou M; Parsopoulou F; Vatsiou S; Psarros F; Csuka D; Porebski G; Obtulowicz K; Valerieva A; Staevska M; López-Lera A; López-Trascasa M; Moldovan D; Magerl M; Maurer M; Speletas M; Farkas H; Germenis AE
    Gene; 2018 Aug; 667():76-82. PubMed ID: 29753808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A first of its kind quantitative functional C1-esterase inhibitor lateral flow assay for hereditary angioedema point-of-care diagnostic testing.
    Chockalingam PS; Zhou Z; Garg BK; Boehringer H; Chung R; Fait S
    Int Immunopharmacol; 2020 Jun; 83():106526. PubMed ID: 32361670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
    Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
    J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary angioedema: Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis.
    Khan DA
    Allergy Asthma Proc; 2011; 32(1):1-10. PubMed ID: 21262092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
    Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
    Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.